Edesa Biotech, Inc. Common Shares
$4.14
$0.27 (+6.98%)
$3.91Day Range$4.20
Key Statistics
Market Cap
$39.91M
Shares Outstanding
9.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 9, 2010
Round Lot
100
Locale
US
Trading Data
Day Open
$3.93
Day High
$4.20
Day Low
$3.91
Volume
24.8K
VWAP
$4.06
Prev Close
$3.87
Transactions
--
Acc. Volume
--
About Edesa Biotech, Inc. Common Shares
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
PHARMACEUTICAL PREPARATIONSSIC 283417 employees100 SPY COURT, MARKHAM(905) 475-1234IPO Jun 9, 2010US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001540159
- Composite FIGI
- BBG000R0LC72
- Share Class FIGI
- BBG001SPM284
- Ticker Root
- EDSA
- SIC Code
- 2834
About Edesa Biotech, Inc. Common Shares (EDSA) Stock
Edesa Biotech, Inc. Common Shares (EDSA) closed the 2026-09-17 session at $4.14, up 6.98% versus the previous close (+0.27). The stock opened at $3.93 and traded between $3.91 and $4.20 during that session. Session trading volume was 25K shares. The volume-weighted average price (VWAP) is $4.06.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Edesa Biotech, Inc. Common Shares has a market capitalization of $39.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. EDSA is listed on the XNAS exchange. The company employs approximately 17 people. The recorded listing date is 2010-06-09.
On this page you can find market EDSA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.